Company Overview
Snapshot
Founded in January 2007 by Shlomo Turgeman, IDEA Bio-Medical operates with 1–10 employees. The company specializes in image-based screening platforms for biological cell research and drug discovery. In March 2017, IDEA Bio-Medical introduced a new feature for spatio-temporal analysis of rare events using high-content microscopy, enhancing its product capabilities.
Business overview
IDEA Bio-Medical is a commercial-stage company focused on developing solutions for biological cell-imaging research, drug-discovery automation, and diagnostics. Its core technology involves high-definition, ultra-fast biological cell-imaging systems, such as WiScan Hermes, designed to improve drug-discovery processes and reduce R&D costs in biomedical and pharmaceutical sectors. The company serves the Health Tech & Life Sciences sector, particularly targeting pharmaceutical companies, laboratories, and medical technology industries with its screening and data analytics software applications.
Strategic signal
In March 2017, IDEA Bio-Medical launched a new feature for spatio-temporal analysis of rare events using high-content microscopy. This development signals the company's continuous innovation in advanced imaging techniques, offering enhanced capabilities for researchers and drug discovery teams to analyze complex biological processes more effectively. For investors, this indicates a commitment to product evolution and maintaining a competitive edge in the high-content screening market.
Log in to access full profile ›Company Intelligence Q&A
- When was IDEA Bio-Medical founded?
- IDEA Bio-Medical was founded in January 2007.
- What is IDEA Bio-Medical's primary focus?
- IDEA Bio-Medical specializes in image-based screening platforms for biological cell-imaging research, drug-discovery automation, and diagnostics.
- What is the WiScan Hermes system?
- The WiScan Hermes is IDEA Bio-Medical's high-definition, ultra-fast biological cell-imaging system, designed to improve drug-discovery processes.
- Has IDEA Bio-Medical partnered with other research entities?
- Yes, IDEA Bio-Medical has joined forces with European research teams to develop solutions in super-resolution microscopy, regenerative medicine, immunology, and bio-medicine, under the framework of the European Union's seventh program.
- What was a significant product sale for IDEA Bio-Medical?
- In February 2012, IDEA Bio-Medical sold its HTS/HCS Cell Imaging System to the Medical University of South Carolina.